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INTRODUCTION
Liver plays an important role in homeostasis. Any disease affecting the functions of liver 
will  cause  a  breach  in  whole  body  homeostasis.  Liver  plays  a  major  role  in  carbohydrate 
metabolism, lipid metabolism and protein metabolism. Its role in endocrine and hematological 
manifestations  are  important.  Loss  of  Liver  function  can  manifest  as  subtle  metabolic 
abnormalities and derangements in hematological parameters which can ultimately culminate 
in grave complications.
Liver plays a major role in maintaining the hematological  parameters in normal and 
maintain the hemostasis. Liver is the storage site for iron, B12 and folic acid which are necessary 
for the normal hematopoiesis. Liver also secretes the clotting factors and the inhibitors and 
keep the hemostasis in equilibrium.
Hepatocellular failure, portal hypertension and jaundice may affect the blood picture. 
Chronic  Liver  disease  is  usually  accompanied  by  hypersplenism.  Diminished  erythrocyte 
survival is frequent. In addition both parenchymal hepatic disease and cholestatic jaundice may 
produce blood coagulation defects. Dietary deficiencies, alcoholism, bleeding and difficulties 
in hepatic synthesis of proteins used in blood formation or coagulation add to complexity of the 
problem.
Spontaneous bleeding, bruising and purpura together with a history of bleeding after 
minimal trauma such as venepuncture, are most important indications of a bleeding tendency in 
patients with liver disease than lab tests.
The hematological abnormalities in a chronic liver disease adds morbidity to the primary 
pathology  and  increases  the  mortality.  Hence  it  becomes  necessary  to  investigate  the 
hematological abnormalities and hemostatic abnormalities to decrease the comorbidity.
The  study  was  conducted  to  assess  the  hematological  abnormalities  and  hemostatic 
derangements  and the nature of hemotological abnormalities, so that the treatment can be done 
towards the line to decrease the morbidity. Broadly the hematological abnormalities are viewed 
under :
1. Abnormalities of formed element
a. RBCs
b. WBCs
c. Platelets 
2. Coagulation abnormalities :
a. Impaired synthesis of clotting factors
b. Decreased inactivation of activated factors.
AIM OF THE STUDY
1. To assess  the  hematological  abnormalities  in  a  decompensated chronic  liver  disease 
patient.
2. To detect the abnormalities in RBCs in a cirrhosis patient.
3. To find the type of anemia in a patient with chronic decompensated  liver disease.
4. To assess the WBC abnormalities.
5. To detect the platelet abnormalities both quantitatively and qualitatively.
6. To assess the secretion and function of clotting factors in the patients with cirrhosis.
REVIEW OF LITERATURE
Liver
Liver  is  one of  the  largest  organ  in  the  body.  It  is  the  largest  organ weights  about 
1200-1500 gm about 1/5 of total adult body weight. In infancy it is about 1/8th of birth weight. 
Liver is divided into 8 functional segments by various planes. They are grouped in to 4 sectors. 
Right anterior (V & VII), Right posterior (VI & VII), Left medial (IV) and left lateral with 
regard to portal, arterial supply and bile drainage.
Functions of liver
1. Formation and secretion of bile
2. Storage function
Glycogen storage
Lipid storage
B12 and Folic acid storage
Fat and water soluble vitamins
3. Inactivation of various substances
Toxins
Steroids
Hormones
4. Secretion of plasma protein
Albumin
Fibrinogen
α1-antitrypsin 
Ceruloplasmin
Haptoglobins
Transferrin
C3 component of complement
5. Synthesis of Immuno globulins,
IgG, IgM, IgA
6. Synthesis of Urea
Chronic  liver  disease  or  progression  leads  to  irreversible  chronic  injury  to  liver 
parenchyma  and  intensive  fibrosis  with  associated  formation  of  regeneration  nodules.  The 
above condition is defined as cirrhosis of liver (2, 3, 4, 5, 6).
According to functional status of liver is cirrhosis it may be compensated cirrhosis or 
decompensated cirrhosis.
Compensated cirrhosis.
Cirrhosis discovered at routine examination or biochemical reaction with external signs 
and symptoms of  liver  failure  like  nausea,  vomiting,  indigestion,  flatulence,  dyspepsia,  are 
early features in alcoholic cirrhosis. It may be suspected in patients with mild pyrexia, vascular 
spiders, palmar erythema, unexplained epistaxis or edema of ankles.
Firm enlargement of liver and splemomegaly may be present. Diagnosis by liver biopsy. 
These will be a slight increase in serum transaminase or  γ-GT level.  Sometimes associated 
portal hypertension may be present.
Decompensated cirrhosis
Patient presents with signs of liver cell failure usually of ascites, jaundice. Continuous 
mild  fever  is  often  due  to  gram  negative  bactremia,  continuing  hepatic  cell  necrosis  or 
malignant  transformation.  Jaundice  implies  liver  cell  destruction,  exceeds  the  capacity  for 
regeneration and is always serious.
Chronic liver disease
Liver disease over a period of 6 months is termed as chronic liver disease.
Most common causes:
1. Chronic hepatitis C infection
2. Chronic hepatitis B infection
3. Alcohol induced
4. Fatty liver
5. Auto immuno hepatitis
6. Primary bilary cirrhosis
7. Sclerosing cholangitis
8. Hemochromatosis/Wilson's
Classification of cirrhosis based on etiology:
1. Alcoholic
2. Post necrotic or post infective HBV/HCV/HBV & HDV
3. Drugs and toxins
4. Autoimmune chronic liver disease
5. Metabolic disorders
a. Hemochromatosis
b. Wilson's
c. Alpha antitrypsin deficiency
d. Cystic fibrosis
e. Glycogen storage disease
f. Galactosemia
g. Hereditary fructose intolerance
h. Hereditary tyrosinemia
i. Ornithine trans carbomylase deficiency.
j. Abetalipoproteinemia
k. Porphyria
6. Biliary tract disease
a. Extra hepatic biliary obstruction
b. Intra hepatic biliary obstruction
c. Primary biliary cirrhosis
d. Primary sclerosing cholangitis
7. Venous outflow obstruction
a. Veno occlusive disease
b. Budd-chiari syndrome
c. Cardiac failure
8. Others
a. Obesity, diabetes mellitus
b. Intestinal bypass
c. Sarcoidosis
e. Indian childhood cirrhosis
Clinical features of cirrhosis
1. Weakness, muscle wasting and weigh loss
2. Low grade fever
3. Jaundice
4. Skin pigmentation
5. Ascites, Edema of legs
6. Purpura/spontaneous bruising
7. Loss of libido gonadal atrophy
8. Sparse body hair
9. White nails palmar erythema
10. Vascular spiders
Clinical manifestation in chronic liver disease is due to
(i) Portal hypertension
(ii) Hepato cellular failure
Stigmata of chronic liver disease
Face
Parotid enlargement
Loss of eye brows
Xanthelasma,
Telengectasia 
Paper money skin
Shrunken facies
Hands
Pallor
Anemia
White nails
Duputyren's contracture
Palmar erythema
Clubbing
Skin
Spider nevi
Scanty body hair
Slate grey pigmentation
Scratch marks
Nutrition
Muscle wasting
Glossitis
Angular stomatitis
Anaemia
Endocrine
Gynaecomastia
Testicular atrophy
Features due to portal hypertension
Splenomegaly
Ascites
Esophageal varices
Anorectal varices
Dilated veins over abdomen
Role of liver in hematopoiesis and hemostasis
Liver plays an important  role both in hematopoiesis  with hemostatis  Liver acts as  a 
storage organ for vitamin B12 and folic acid which are necessary for the maturation of RBCS 
and WBCs. Liver secretes transferrin which is necessary for the transport of iron from the site 
of absorption to bone marrow for the synthesis of heme and RBCs production.
Liver plays a key role in B12 metabolism in taking part in enterohepaic circulation and 
also secretes transcobalamin I, necessary for the transport of B12 to the storage site.
Liver is one of the primary site of reticulo endothelial system, contains plenty of kupffer 
cells, plays an important role in immunity and secretes immunoglobulin.
Thrombopoietin, a regulator of platelet synthesis is secreted by liver.
Role of liver in hemostasis
Where the vessel is injured, three hemostatic responses are initiated.
1. The blood vessel constricts
2. Platelets adhere at the site of damage and aggregation.
3. Fibrin clot is formed and modified
The hemostatic response occurs in stepwise fashion. First the blood vessel constricts, 
followed it the platelets adhere aggregate and forms a temporary plug. It was reinforced with a 
fibrin clot, through a coagulation cascade. The fibrin clot is modified and after tissue healing, it 
is  dissolved by fibrinolytic components.
The role of liver in hemostasis is through the synthesis of thrombopoietin, regulator of 
platelet  production  and  synthesis  of  clotting  factors.  Liver  is  also  a  site  of  synthesis  of 
inhibitors  of coagulation cascade and also the regulator of fibrinolysis.  Thus liver is a key 
regulator of hemostasis.
Clotting factors
Clotting factors are the key factors in coagulation cascade. The summary of coagulation 
cascade as shown below.
Liver is the principal site of synthesis of all the coagulation protein with the exception of 
VWF and factor VIIIC. The proteins include.
Vitamin K dependant  factors - II, VII, IX & X
Labile factor - V
COAGULATION CASCADE
COAGULATION
Intrinsic system
HMW  kininogen
Kallikrein
XI
XIIa
HMW  kininogen
XIa
XII
IX IXa
Extrinsic System
TPL
VIIa VII
VIII
PL
Ca2+
VIIIa
Ca2+
PL
TPL
X Xa
PL
Ca2+
VaV
II Thrombin
Fibrinogen Fibrin
XIII XIIIa
Sta
biliz
atio
n
Contact factor - XI & VII
Fibrinogen and fibrin stabilising factors
Liver is the site of vitamin K storage. The vitamin K is essential for the synthesis of 
factors II, VII, IX and X. The function of these blood clotting protein depends on the 
conversion  of  glutamic  acid  residues,  post  ribosomally  to  γ-carboxy  glutamic  acid  by  a 
carboxylase that requires vitamin K.
Inhibitors of coagulation cascade are also synthesized by the liver
These are Antithrombin III
Protein C & S
Heparin cofactor II
Here too protein C & S are vitamin K dependant. Liver also synthesis plasmin inhibitors 
such as α2-antiplasmin and tissue plasminogen activator inhibitor.
Hematological abnormalities in liver disease
Plasma volume
Plasma volume is frequently increased in patients with cirrhosis especially with ascites. 
Hypervolemia caused low peripheral hemoglobin or erythrocyte level.
Anemia is liver disease
Anemia occurs in 75%34, 35 of patients with chronic liver disease. It is mostly of moderate 
severity and is either normochromic normocytic or moderately macrocytic in uncomplicated 
cirrhosis36.  If  cirrhosis  is  complicated  with  hemorrhage  or  hemolysis  then  microcytic 
hypochromic anaemia can occur.
Anaemia in uncomplicated cirrhosis is due to
i. Hemodilution - due to increased plasma volume.
ii. Shortened red cell survival-hypersplenism
iii. Reduced bone marrow response to anaemia due to reduced erythropoietin level, 
chronic  inflammation  and  increased  level  of  inflammatory  cytokines  suppress  the  bone 
marrow4.
Patient with cirrhosis have a low oxygen -hemoglobin affinity which increased tissue 
oxygen availability, leads to better tolerance of anaemia5.
Liver disease and hematinic metabolism
Iron metabolism
Low  or  normal  serum  iron  concentration  with  a  low  or  normal  total  iron  binding 
capacity  is  frequently  found  in  uncomplicated  cirrhosis6.  In  alcohol  induced  liver  disease, 
alcohol has toxic effect and suppresses the bone marrow but it increases the iron absorption 
from the GIT7,8. Hepatic inflammation and necrosis tend to increase serum ferritin.
The  rise  in  MCV  which  accompanies  CLD  and  alcohol  ingestion  masks  the  iron 
deficiency. Serum iron is bound to Beta globulin transferrin which is synthesized in liver, total 
iron binding capacity largely depends on the transferrin concentration. High total iron binding 
capacity  indicates  iron  deficiency.  TIBC  is  often  lowered  the  patients  with  CLD  due  to 
decreased synthesis of transferrin6. Serum transferrin receptor level is a more reliable lab index 
of iron deficiency in patients with liver disease11.
Iron deficiency also associated with hemorrhage and hemolysis. Iron deficiency causes 
microcytic hypochromic anaemia.
Vitamin B12 and Folic acid metabolism
Liver stores 5-10 mg of vitamin B12 representing 50-90% of body stores. Intrinsic factor 
is required for B12 absorption and there is significant enterohepatic circulation37.  Pernicious 
anaemia is associated with primary biliary cirrhosis. Alcohol inhibit B12 absorption, elevated 
B12 binding capacity occurs in cirrhosis and hepatocellular carcinoma12.
Liver stores of folic acid are sufficient for only 4 to 5 months14. Alcohol induced liver 
disease and poor nutrition results in disordered folate metabolism15. Hepatic necrosis leads to 
increased release of folate from liver and leads to increased urinary excretion.
Altered B12 and folate metabolism causes macrocytosis.
Hemolytic syndromes in liver disease
Red cell life span is reduced by about 50% in cirrhotic with the spleen as major site of 
destruction. Reticulocytosis is frequently seen in CLD. The hemolysis may be due to
Hypersplenism16
Lipid abnormalities
Hemolytic  anaemia  is  also  seen  in  Wilson's  disease  and  in  autoimmune  hepatitis 
(Coombs positive).
Intracorpuscular defects such as instability of pyruvate kinase enzyme in alcohol CLD 
leads to hemolysis.
Abnormalities of red cell shape
1. Macrocytosis is seen mostly in alcoholics18. The increase in MCV is due to
- Increase in RBC membrane cholesterol and phospholipid content
- Reticulocytosis  associated with hemorrhage and hemolysis
- Abnormalities in B12 and Folic acid metabolism
- Intrinsic abnormality in bone marrow erythropoiesis
2. Target  cells  bowel  or  saucer  shaped,  seen  in  most  of  CLD as  their  red  cell 
membrane contains more cholesterol or more cholesterol and phospholipid
3. Echinocytes: Spiculated red cells due to changes in HDL41 in CLD patients20.
4. Acanthocytosis:  Seen in  severe  liver  disease.  It  is  a  bad prognostic  indicator. 
Where it is associated with hemolytic anaemia it is called spur cell anaemia19.
Table 1: Abnormality of RBCs
Abnormality Primary liver disorders Disease in other systems
Macrocytes Many types of liver disease Megaloblastic anaemia
Hypothyroidism, cytotoxic drugs
Target cells Many types of liver disease Thalassaemia
Other haemoglobinopathies
Hyposplenism, e.g. SLE, coeliac disease
Spherocytes Zieve's syndrome Hereditary spherocytosis
Autoimmune haemolytic anaemia
Burns
Echinocytes 
Acanthocytes
Severe  chronic  liver  disease 
Very severe disease (especially 
alcoholic) (Spur-cell anaemia)
Haemolytic anaemia
Abetalipoproteinaemia
Anorexia nervosa/malnutrition
McLeod phenotype
Burr  cells  Fragmented 
cells (schistocytes)
Hepatorenal syndrome Renal failure
Thrombotic thrombocytopenia purpura
Microangiopathic haemolytic anaemia
DIC, HELLP syndrome
Some haemoglobinopathies
Stomatocytes
Tear-drop poikilocytes
Alcoholic cirrhosis Alcoholism
Haemolytic anaemias
Primary and secondary myelofibrosis
Nucleated  red  cells 
Punctate basophilla
Acute fatty liver of pregnancy Many causes
Infections, e.g., malaria
Heavy metal poisoning
Haemolytic/dyserythropoietic anaemia
Rouleaux 
Autoagglutination 
Sickle cells
Myeloma/macroglobulinaemia/lymphoma
Autoimmune haemolytic anaemia
Sickle-cell disease
Courtesy: Oxford text book of hepatology
WBC changes in liver disease
WBC  abnormalities  in  liver  disease  may  be  due  to  the  underlying  disease  or  its 
therapy38.  Leucocytosis  can  occur  in  response  to  infection,  hemorrhage,  hemolysis  and 
malignancy. Eosinophilia is frequently seen in associated with parasitic disease, hepatocellular 
carcinoma, hepatic.v thrombosis, drugs induced and also in primary biliary cirrhosis26.
Leucopenia seen in CLD is  due to hypersplenism or a  toxic effect  on bone marrow 
(alcohol)24.  In neutrophil  function there is a disturbance in late maturation compartment of 
granulocyte differentiation. Chemotaxis is inhibited. There is a low level of complement C323.
Hypergamma globulinemia is a well recognised feature of cirrhosis. It  is initiated by 
immunisation  with enteric  organism normally  filtered  by  liver.  IgG and IgA are  markedly 
increased.  There  is  generalised  immunological  hyperactivity22.  Benign  monoclonal 
gammopathy is associated with primary biliary cirrhosis.
Platelets in liver disease
Defects  of  platelet  number and function are well  documented in patients  with CLD, 
contributing  significantly  to  their  hemostatic  abnormalities.  The  mechanism  for 
thrombocytopenia are: 28,29,30
1. Shortened mean platelet life span
2. Platelet pooling in an enlarged spleen
3. Inability of marrow to compensate
4. Reduced thrombopoietin production
5. Platelet associated immunoglobulin.
There  is  no clear  relationship  between the  abnormalities  of  platelet  kinetics  and the 
severity of liver disease as very low platelet count often accompany portal hypertension and 
splenomegaly in patients with relatively normal liver function31.
There is a growing evidence of impaired platelet function in CLD and of impairment of 
aggregation  by  intrinsic  platelet  defects  and  circulating  inhibitors  of  aggregation.  Normal 
platelets  enriched  with  cholesterol  show increased  aggregability  by  ADP and  adrenaline27. 
Platelets  in  liver  disease  tend  to  be  cholesterol  rich  but  their  aggregability  is  diminished, 
probably because the arachidonic acid content of platelet phospholipids is reduced.
Cross  incubation  studies  suggested  the  possibility  of  circulating  inhibitor  of  platelet 
aggregation in CLD.
HDL isolated from patients with cirrhosis inhibited ADP induced platelet aggregation, 
related to high apolipoprotein E content. It is also reported that basal cytosolic calcium content 
in platelets from cirrhosis was lower than of control. Platelets from patients with cirrhosis also 
exhibit a defect in VWF-binding domain. A rised level of platelet associated immunoglobulin 
is found in patients with CLD such as primary biliary cirrhosis, alcoholic cirrhosis, chronic 
active hepatitis.
Hemostasis in chronic liver disease
The abnormalities in hemostasis in CLD are due to43,44
i. Impaired synthesis of clotting factors.
ii. Synthesis of abnormal clotting proteins
iii. Quantitative, qualitative platelet defect
iv. Enhanced fibrinolytic activity
v. Disseminated intravascular coagulation.
Decreased clotting factor levels46
Factors  II,  VII,  IX  and  X are  vitamin  K  dependent  clotting  factors  as  well  as  the 
coagulation. Inhibitor Proteins C & S. Factors VII is usually first to be decreased due to its 
short  half  life.  The  non  functional  precursor  forms  of  clotting  factors  are  called  proteins 
induced  in  vitamin  K absence  (PIVKA)  are  present  due  to  defective  carboxylation  in  the 
presence of vitamin K deficiency. Factor V is synthesized in liver in the absence of vitamin K44. 
Thus a decreased level of factor V associated with decreased levels of factor II, VII, IX and X 
is an indicator of hepatocellular insufficiency46.
Hypofibrinogenemia is less frequent, until there is severe liver damage46. Factors XI, XII 
and high molecular weight kininogen are usually moderately decreased. Prekallikrein decreases 
early as liver disease. Factor XIII, a fibrin stabilizing factors is also decreased48.
Decreased coagulation inhibitors
Antithrombin  III  is  decreased  in  hepatocellular  insufficiency.  The  deficiency  is  not 
severe and usually parallels that of factor V. The synthesis is only affected by general damage 
to liver. Protein C deficiency parallels the deficiency of other vitamin K dependent factors. The 
level of protein S remains significantly greater due to extrahepatic source of protein S48.
Although  levels  of  natural  occurring  inhibitors  of  blood  clotting  are  decreased  in 
hepatocellular  insufficiency clinical  evidence of  thrombo embolism is  rarely  noted.  This  is 
probably due to the balance maintained between these inhibitors and the procoagulants48.
Factors  VIII  is  usually   elevated  in  CLD49,  which  reflects  extrahepatic  synthesis 
associated with decreased catabolism by the diseased liver. But there is some abnormality in 
VWF binding domain.
Fibrinogen and prothrombin
Functional  abnormalities  of  fibrinogen molecule  are  known as  dysfibrinogenemias53. 
Acquired dysfibrinogenemias are most often associated with CLD. Defective polymerisation 
results from an abnormal glycosylation of fibrinogen molecules54.  Increased levels of sialyl 
transferase has been demonstrated in liver  patients  with dysfibrinogenemias.  Impairment in 
fibrin formation results in prolonged thrombin time.
Abnormal  type  of  prothrombin  due  to  defective  carboxylation  is  des-γ-carboxy 
prothrombin is increased in chronic active hepatitis, cirrhosis and hepatocellular carcinoma55.
Fibrinolysis
Enhanced fibrinolysis is CLD is due to decreased, hepatic synthesis of inhibitors  α2-
antiplasmin and plasminogen activator inhibitor as well as decreased clearance of tissue type 
plasminogen activator.
Disseminated intravascular coagulation58
DIC is due to the consequence of non compensated formation of thrombin and leads to 
the formation of platelet thrombi and fibrin within the circulation57. Thus it is associated with 
activation and consumption of circulating platelets and consumption of factors V, VIII, VII, II 
& XIII Protein C & S, antithrombin III, plasminogen and α2 plasmin inhibitor.
The  release  of  tissue  thromboplastin  like  material  by  necrotic  liver  had  been  the 
trigerring factor for DIC in severe liver failure59. Increased fibrinopeptide. A levels have been 
found  in  patients  with  cirrhosis  and  chronic  hepatitis.  Elevated  level  of  thrombin  -  anti 
thrombin  complexes  have  been  reported  in  chronic  active  hepatitis,  decompensated  liver 
disease, end stage liver disease and fulminant liver failure.
Table - 2
Combination of haematological abnormalities with abnormal liver function tests
Abnormality Haematological indices Primary liver 
disease
Disease in other systems
Red cells anaemia Increased  MCV 
(macrocytic)
Many liver diseases Alcoholism
Vitamin B12/folate deficiency
Haemolysis (reticulocytes up)
Low  MCV/MCHC 
(microcytic)
Normochromic, normocytic
High reticulocyte count
Low reticulocyte count
With iron deficiency
With  dilutional 
anaemia
With hypersplenism
With  marrow aplasia 
(viral hepatitis)
Thalassaemia
Anaemia of chronic disease
Haemolysis
Paroxysmal  noctural 
haemoglobinuria  (±  Budd-
Chiari syndrome)
Normal  haemoglobin 
Erythrocytosis
Increased MCV
Low MCV
Mild liver disease
With iron deficiency
Hepatocellular 
carcinoma
Viral hepatitis (rae)
Alcoholism
Thalassaemia trait
White cells Increased
Neutrophils increased
Lymphocytes increased 
Eosinophils increased
With  infection, 
neoplasia 
inflammation
With  bacterial 
infection  or  steroid 
therapy
Viral infections
Parasitic infection
Drug hepatitis
Chronic  active 
hepatitis  (rarE), 
sarcoidosis
Myeloproliferative disorder
Leukaemia, lymphoma, drugs
Connective tissue disorders
Monocytes  increased 
Basophils/mast  cells 
increased
Tuberculosis,  Leukemia, 
myeloproliferative  disease 
mastocytosis
Decreased With  infection, 
marrow  aplasia,  or 
hypersplenism
Infections  (typhoid,  SBE, 
tuberculosis,  septicaemia) 
leukaemia
Lymphocytes decreased Viral infections
Platelets
Increased
Decreased
Liver  disease  And 
haemorhage, 
neoplasia 
inflammation
With  hypersplenism, 
viral hepatitis
Myeloproliferative disorder
Leukaemia/lymphoma 
Connective  tissue  disorders 
Paroxysmal  noctural 
haemoglobinuria
Courtesy: Oxford text book of hepatology
DESIGN OF STUDY
MATERIALS AND METHODS
To Assess the hematological abnormalities in chronic liver disease, the prevalence study 
was conducted in Government General Hospital, during the period from June 2005 to August 
2006. About one hundred patients were selected in random for this study.
All  of  the  cases  in  the  study  were  admitted  in  the  hospital  ward  and evaluated  for 
chronic liver disease and for the study to assess the hematological abnormalities. Oral consent 
of the patients got for the clinical examination and for the lab investigations. Written consent 
also got for the special procedures such as liver biopsy, upper GI endoscopy and viral markers 
study.
All  the  patients  were  interrogated  regarding  the  presenting  complaints,  duration  of 
illness,  bleeding tendencies,  abdominal distension,  jaundice, oliguria.  Past  history regarding 
previous treatment history, any history of diabetes, hypertension, tuberculosis, coronary heart 
disease. History regarding past history of any trauma, blood transfusion, surgery needle pricks, 
contact with blood products.
Personal history regarding alcoholism, smoking, high risk behaviour also got. Family 
history  of  any  liver  disease  in  their  family  member  was also noted.  Then the  patient  was 
subjected to general examination and systemic examination.
Patients were submitted to a number of blood investigations. Blood samples obtained 
from the patients were personally handed over to laboratory. The results were got in person and 
was noted. Blood sample were anticoagulated with EDTA.
Patients were evaluated for chronic liver disease to establish the diagnosis of cirrhosis. 
Liver  biopsy  with  consent  was  done  to  confirm the  diagnosis.  In  patients  with  defects  in 
coagulation  ie  increased  prothrombin  time   or  decreased  platelet  count,  there  is  increased 
bleeding tendency during liver biopsy. So in that case diagnosis is established with ultrasound 
and CT scan abdomen.
According  to  Schalm  Sw.  The  diagnosis  of  cirrhosis  J.Hepatol  1997;  27:  1118, 
ultrasound can pick up 87% of cirrhosis and should be confirmed by liver biopsy.
In the setting of contraindication to liver biopsy, suspicious of cirrhosis with ultrasound 
is coupled with evidence of portal gastropathy or varices in upper GI endoscopy or with portal 
doppler to gain more evidence of diagnosis. Above investigations were also supported with 
signs of liver cell failure, to establish diagnosis.
After establishing the diagnosis patients were evaluated for hematological abnormalities. 
All  blood  investigations  regarding  hematological  profile  were  done  in  clinical  pathology 
laboratory in Government General Hospital. Some investigations such as MCV, MCH, MCHC 
were  done  at  outside  lab,  when the  kit  for  testing  was not  available,  along with  all  other 
hematological  profiles,  to  have  some  control  and  to  prevent  the  observers  error  if  done 
separately.
Similarly  prothrombin  time  and  activated  partial  thromboplastin  time  were  done  at 
pathology laboratory, or together in laboratory outside which has same control test of PT & 
APTT as our pathology lab, when kits were not available in the pathology laboratory.
To assess RBC abnormality
1. RBC count:
RBC count  are  done  in  Neubauer's  chamber  using  Hayem's  fluid  or  auto  analyser. 
Normal value : 4.5 to 6 million per mm3
2. Hemoglobin  estimation:
Done by Sahli's method, based on conversion of hemoglobin to acid hematin or 
acid analyser. Normal value : Male 14 to 18 Gm%, Female 12 to 16 Gm%.
3. Packed cell volume (PCV)
It is done in autoanalyser or using microhematocrit capillary method.
Normal value : Male 42 to 52%. Female: 37 to 47 %
4. MCV, MCHC, MCH:
- are estimated by autoanalyser
MCV - 80 to 97 fl
MCH - 26 to 33 pg/dl
MCHC - 32-35 gm/dl
5. Peripheral smear for blood picture
Using stains, blood picture is examined with a lab microscope.
Low power field examination:
- Quality of film
- Number, distribution and staining of WBCs
- RBCs examination
High power field examination:
Assess RBC - Size
Shape
Hemoglobin concentration
Oil immersion examination:
Assess atypical cells and inclusion bodies
6. Reticulocyte count:
Stain - 1% brilliant cresyl blue
Normal - 0.2-2%
To assess WBC abnormality:
1. Total WBC count
Done by QBC method or using Neubauer's chamber with Turke's fluid
Normal 3,800-9,000 cells per mm3
2. Differential count
Assessed by QBC method or direct staining and visualizing with lab microscope.
To Assess hemostasis
1. Platelet count
Manually is done by Rees-Eecker method i.e with staining with brilliant cresyl blue dye 
or by auto analyser.
1. Prothrombin time: Normal 10-14 sec.
2. Activated partial thromboplastin time: Normal 24-34 sec.
Liver biopsy
Liver biopsy is done with Menghini's needles under the guidance of ultrasound. Before 
the procedure patient written consent was got, patient was explained about the procedure and 
the  side  effects  of  the  procedure.  Patient  was  evaluated  for  any  contraindications  such  as 
bleeding disorders, poor general condition, known malignancy, tense ascites. Biopsy  specimen 
was handed over to pathologist in person and the results were collected in person.
Upper GI endoscopy
UGI  endoscopy  was  done  at  medical  gastroenterology  department.  After  obtained 
patient's written consent, patients was explained about the procedure, side effects. Patients were 
kept on over night nil oral and was done upper GI endoscopy. Results were collected in person 
and was correlated with other finding to establish the diagnosis.
Inclusion criteria
1. All liver disease patients whose symptoms and signs persists more than 6 months
2. Alcoholic and post infective, metabolic causes of liver diseases are taken for study
Exclusion disorder
1. Patients with known GIT malignancy or known primary hepatocellular carcinoma.
2. Patients with primary coagulation disorder.
3. Acute liver cell failure
4. Liver cell failure due to infective cause and patients with other causes of septicemia 
or endotoxemia other than primary liver causes.
DATA ANALYSIS
This study regarding assessment of hematological profile and hemostasis was conducted 
among 100 inpatients in medical department at Government General hospital.
Out of 100 patients is this study, there are 80 male patients and 20 female patients. The 
age of patients in this study were in the range from 20 to 60.
Table 3: Age of patients
Age in yrs. Male Female Total Percentage
20 to 30 4 2 6 6%
30 to 40 25 10 35 35%
40 to 50 36 6 42 42%
50 to 60 15 2 17 17%
Most of the patients in the study were in the middle age group and only 6% were in 
younger age. Out of six patients two patients were diagnosed to have Wilson's disease and 
others  were  of  unknown  etiology.  Remaining  94  patients  were  diagnosed  as  chronic 
decompensated liver disease with pathology as cirrhosis and were of variable etiology.
Alcoholism
Among 20 female patients,  none gave history of alcoholism and among the 80 male 
patients 62 patients were found to be alcoholic.
Past history of jaundice
Among  100  patients  only  32  patients  had  past  history  of  jaundice.  Later  serology 
investigation for HBV Ag, anti HCV antibody shows 12 patients were positive for HBS Ag 
and only one shows positive for anti HCV antibody.
While coming to data analysis of investigations, among the 100 CLD patients only 86 
patients has rised bilirubin level. About 14% of the patients were with normal bilirubin level.
Serum proteins 
Patients  were  analysed  for  the  estimation  of  serum proteins,  which  is  the  synthetic 
function of  the liver  and evaluated for  albumin globulin ratio which will  be altered in the 
chronic liver disease patients.
Table - 4: Serum proteins in CLD
Total proteins gm% No. of patients Percentage
>6 14 14%
6 to 5 42 42%
5 to 4 43 43%
<4 1 1%
Among 100 patients only 14% had total proteins more than 6 gm% and only one patient 
had total protein <4 gm% and others in the middle group. 42% patients had protein in the range 
of 6-5 gm% and 43% had 5-4 gm% proteins range. All the 100 patients had albumin globulin 
ratio reversal, which is again towards the diagnosis of CLD.
Analysis of RBCS
Patients in the study were analysed for the presence and absence of anaemia and the 
characteristics of anaemia when present.
Eight  eighty  patients  had anaemia and only  twelve patients  had  normal  hemoglobin 
above 12 gm%. About 32 patients had severe anaemia less than 8 gm%.
Characteristics of anaemia
All  the  twelve  patients  with  normal  hemoglobin  level  had  normochromic  and 
normocytic  blood  picture.  Among  the  88  patients  52  patients  had  normochromic  and 
normocytic anaemia, 31 patients had microcytic anaemia and 16 patients had macrocytosis. 
Only one had dimorphic anaemia. Five patients with microcytic anaemia showed anisocytosis 
and poikilocytosis. Target cells were seen in only three patients. Acanthocytes was not seen in 
any of the peripheral smears. Patients with macrocytosis had mean corpuscular volume more 
than 97 fl.
Table - 5: Anemia in CLD
Haemoglobin gm% Cases Percentage
<6 3 3%
6 to 8 29 29%
8.1 to 10 44 44%
10.1 to 12 12 12%
12.1 to 18 12 12%
>14 Nil
Table - 6: RBC count in CLD
Total RBC count Cases Percentage
25 to 3 million/mm3 18 18%
3 to 3.5 28 28%
3.5 to 4 32 32%
4 to 4.5 10 10%
> 4.5 12 12%
Table - 7: Type of anaemia
Type of RBCs Patients with anaemia Patients with normal 
heamoglobin
Normocytic 52 12
Microcytic 19
Marcrocytic 16
Dimorphic 1
WBC abnormalities
The analysis of WBCs were done with the total count and the differential count. The 
total  count  of  WBCs  range  from  1050/mm3 to  16,100/mm3.  Among  the  100  patients 
leucocytosis were observed in 22 patients with lymphocytosis were observed in 12 patients. 
Eosinophilia was found in only two patients. Leucocytosis were observed in patients with fever 
due  to  secondary  infection  of  ascites  due  to  repeated  paracentesis  and  four  patients  had 
leucocytosis due to spontaneous bacterial peritonitis. Leucopenia is present in 5% of patients. 
Lymphocytosis is seen in 12% of patients Eosinophilia in  2% of patients.
Table - 8: WBC Count in CLD
Total count in 
Cells/mm3
No. of patients Percentage
<3000 5 5%
3000-6000 13 13%
6000-9000 32 32%
9000-12000 28 28%
>12,000 22 22%
Platelet abnormalities
Patients  with  platelet  count  less  than  1.5  lakhs  were  carriedout  to  have 
thrombocytopenia. Among 100 patients.
Table - 9: Platelet count in CLD
Platelet count 
cells/mm3
No. of patients Percentage
<50,000 8 8%
50,000 - 1,00,000 12 12%
1-1.5 lakhs 26 26%
1.5-2 lakhs 28 28%
>2 lakhs 26 26%
Thrombocytopenia was found to be in 46 patients among 100 cases is the study. Severe 
thrombocytopenia of <50,000 cells/mm3 was found to be in patients with large spleen >8 cms 
and had a history of massive  hemetemesis. Thrombocytopenia was associated with historyof 
atleast an episode of hematemesis. Among the patients with severe thrombocytopenia 4 patients 
were found to have disseminated intravascular coagulation, later confirmed by the rised value 
of APTT and PT and with D dimer estimation.
Among the patients with normal level of platelets about twelve patients had history of 
atleast one episode of hematemesis. Among the 54 patients with normal platelets level about 22 
patients had mild splenomegaly and 12 patients had moderate splenomegaly. In 10 patients 
splenomegaly was observed in USG only.
Abnormalities in coagulation
The liver secretes all the clotting factor except factor VIII and VWF. As we have no 
facility  for  the  estimation  of  individual  clotting  factors,  the  patients  was  assessed  for  the 
coagulation profile by testing for prothrombin time and activated partial thromboplastin time. 
Among the  100  patients  60  patients  had  prolonged prothrombin  time  and 40  patients  had 
normal prothrombin time. There is no correlation between the severity  of jaundice and the 
prolongation of prothrombin time.
Among the 60 patients with prolonged prothrombin time about 38 patients had history of 
atleast  one episode of  hemetemesis.  Bleeding  time was  prolonged in  20  patients  who had 
platelet counts less than 1,00,000/mm3. Liver biopsy was not done with the patients with low 
platelet count and prolonged prothrombotin time due to the risk of increased bleeding.
Among the 100 patients APTT prolonged in almost all patients who had increased PT. It 
was significantly rised in patients with DIC later confirmed by estimation of D-dimer. They 
had history of spontaneous bleeding with internal bleeding and signs of endotoxemia. All the 
four had severe thrombocytopenia with platelets <50,000/mm3.
Bone marrow biopsy was done to all patients except those patients who had abnormal 
coagulation profile. Most of patients had normocellular bone marrow and eight patients had 
hyper cellularity. These was no hypoplastic and a plastic changes. There was no megaloblastic 
change. 
DISCUSSION
The study involving 100 patients done at Government General Hospital has thrown light 
over  the  hematological  abnormalities  of  chronic  liver  disease.  The  results  of  this  study 
conforms with previous published reports.
RBC ABNORMALITIES
In the study we inferred that 88% of the total patients had anemia and among them 32% 
of cases had severe anemia.
According to studies by Kimber C, Deller DJ and Lander H. The mechanism of anemia 
in CLD 1965 and Sheehy W and Berman A, the anemia of cirrhosis, anemia occurs in upto 
75% of patients with chronic liver disease. It is characteristically of moderate severity and is 
either normochromic normocytic or moderately macrocytic.
In our study 32 patients had severe anemia less than eight gm per cent. In uncomplicated 
cirrhosis it is rare to have such low level of hemoglobin as anemia in cirrhosis mostly  due to :
i. Hemodilution
ii. Decreased  erythropoietin  level  as  per  the  study Siciliano Hepatol   1995 who 
showed decreased erythropoietin  level  in  cirrhosis  patients  with anemia when 
compared with patients with chronic anemia due to iron deficiency.
Cirrhosis without anemia is not associated with low erythropoietin levels (Pirsi, J 
Hepatol 1994).
3. Chronic  inflammation  in  cirrhosis  leads  to  increased  levels  of  serum 
inflammatory cytokines such as TNF- α, IL-1 suppress the bone marrow.
But  severe  anemia  in  cirrhosis  will  necessitate  the  investigations  to  rule  out  the 
following conditions :
1. Bleeding esophageal varices
2. Bleeding peptic ulcer
3. Malignancy
4. Hemolysis
5. Bleeding anorectal varices
6. Increased bleeding tendencies
In developing countries like India, people with poor socio economic state already will 
have nutritional  anemia due to iron deficiency and B12 and folic  acid deficiency,  which is 
superimposed with cirrhosis leads to severe anemia. Female patients had a greater proportion of 
severe anemia when compared with males. It shows the poor nutritional status of women in 
developing countries.
SERUM PROTEINS
The  plasma  proteins  produced  by  the  hepatocyte  are  synthesized  on  polyribosomes 
bound to the rough endoplasmic reticulum, from which they are discharged into the plasma. 
According to Tavill AS Fall in concentration usually reflect decreased hepatic synthesis. In our 
study 86% of cases had decreased albumin and total protein level and all the 100 patients had 
albumin  globulin  ratio  reversed.  The  hypoproteinemia  was  also  contributed  by  poor  socio 
economic status of the patients who got admitted at the government hospitals.
The mechanism for the low albumin level in cirrhotics is due to decreased synthetic 
function of liver. In cirrhosis there is a chronic inflammatory4 process in progression which 
causes elevated cytokines level such as IL-1, IL-6, TNF- α inhibits the synthesis of albumin 
and transferrin  by  the  liver.  In  a  study  done  by  Barle  H.  Myberg  B,  Essen  P,  et  al.,  the 
fractional synthetic rate of albumin is approximately 6% per day compared with 25% for total 
liver proteins. About 10 gm of albumin is synthesized by normal liver, where as with cirrhosis 
it synthesis only about 4 gms.
Transferrin is the iron transport protein. The plasma is more than 90% saturated with 
iron in patients with untreated idiopathic hemochromatosis. Reduced values may be found with 
cirrhosis.
CHARACTERISTICS OF ANEMIA
According  to  Sheila  Sherlock  and  Oxford  text  book  of  hepatology.  Most  common 
anemia seen in cirrhotic patients is normochromic and normocytic anemia34,35. It is well proven 
in our study too. The incidence of normochromic normocytic anemia in our patients is 52%, 
where as in some studies there are varied results.
According to study done by Malhotra, 1951, the incidence was 90%. In studies done by 
Bhatia (1961) and Mishra et al., (1982), the incidence were 59% and 79% respectively.
In some studies such as Kimber C.  et  al.,  reported 43% of macocytosis,  which was 
supported also by the study by Bingham et al.
The incidence of macrocytosis in our patients was 16%, macrocytosis in cirrhosis is 
mostly due to the toxic of alcohol on RBC production in the bone marrow and deficiency of B12 
and folic acid37. Folic acid deficiency is also exacerbated with alcohol which was confirmed by 
the study done by Weir, Biochem. Pharm, 1985, and Lindenbaum.
About 19 patients  in  our group and microcytic hypochromic anemia.  Bleeding from 
esophagitis, peptic ulceration or esophageal varices, compounded by the hemostatic defects of 
chronic  liver  disease,  occurs  in  upto  70% of  patients  with  Liver  disease  or  per  the  study 
conducted by Kimber, Philips, et al., microcytosis in cirrohosis due to :
i. Decreased total iron concentration with alterations in iron metabolism due 
to decreased serum transferrin.
ii. Hemolysis due to hypersplenism, autoimmune process, lipid abnormalities 
or intracorpuscular defects16.
Serum iron is bound to β globulin transferrin and total iron binding capacity largely 
depends on transferrin concentration. The TIBC is often lowered in cirrhosis due to reduced 
hepatic synthesis of transferrin. 
ABNORMALITIES OF RBCS
Target  cells  are  also  thin  macrocytes  are  found  in  cholestatic  jaundice  and  hepato 
cellular  jaundice.  They  have  increased  resistance  to  osmotic  lysis.  They  are  particularly 
prominent  in  cholestasis  where  a  rise  in  bile  acids  may  contribute  by  inhibiting  lecithin 
cholesterol acyl transferase (LCAT) activity65 which was proved by the study conducted by 
Cooper RA, Arner EC. It is seen in 2% of patients in our study.
Spur cells or acanthocytes which are associated with advanced liver disease, are bad 
prognostic sign19. They are not found in our study groups. They form because of an interaction 
with the abnormal HDL found in Liver disease40.
Bone marrow of chronic hepatocellular failure is hyperplastic and macro normoblastic as 
per Sheila Sherlock but in our study patients with history of bleeding diasthesis patients had 
hyperplastic marrow and most of the alcoholic had macro normoblastic. 
ABNORMALITIES OF WBCS
According to Sheila Sherlock Leucopenia,  thrombocytopenia are commonly found in 
cirrhotics.  But according to oxford textbook of  hepatology leucocyte abnormalities  in  liver 
disease may be due to the underlying disease or its therapy and range from neutrophilia to 
neutropenia and lymphopenia25. In patients with cirrhosis and systemic inflammatory response 
syndrome leucocyte activation is evident from measurement of leucocyte adhesion molecule 
expression and there is elevation of serum IL-6 evident by the study of Rosenbloom, JAMA, 
1995.
In our study group all  the 100 patients WBC total count are in the range of 1000 - 
16,000 cell per mm3. About 22 patients had leucocytosis which was mostly due to infections 
due to community required infection, nosocomial, infection, spontaneous bacterial peritonitis 
and secondary peritonitis due to repeated peritoneal paracentesis.
In our study group in patients with leucocytosis >12,000 / mm3 of blood most of the 
patients had H/o repeated hospital admissions and had repeated paracentesis. About 50% of 
patients with leucocytosis had high grade fever and all patients with leucocytosis had increased 
cell  count  mostly  of  polymorphs  in  ascitic  fluid  analysis,  which  suggests  the  presence  of 
peritonitis in this group of patients.
Leucopenia is present in 5% of the patients may be due to
i. Direct influences of alcohol on bone marrow.
ii. Chronic inflammatory cytokines had suppressor effect on bone marrow.
iii. Hypersplenism
iv. Infection
Eosinophilia  is  seen  in  association  with  parasitic  diseases  and  also  associated  with 
Hepatic vein thrombosis, hepatocellular carcinoma26, drug allergy and graft rejection. It is also 
found in primary biliary cirrhosis. Serum eosinophilic cationic protein was high in patients with 
primary biliary cirrhosis. Eosinophilia is present in 2% of cases in our study group mostly due 
to parasitic infection.
IMMUNOGLOBULINS AND LIVER DISEASE
As per the studies Feizi Gut 1968 and Jensen Arch Int Med. 1982 it has been proved that 
Hyperglobulinemia is a well recognised feature of cirrhosis.  It  has been suggested that this 
polyclonal  hypergamaglobulinemia  is  initiated  by  immunization  with  enteric  organisms 
normally filtered by the Liver22.
Cirrhosis may be associated with a state of generalised hyperactivity, perhaps as a result 
of a defect of immune regulation. Berger et al., found that peripheral blood mononuclear cells 
from cirrhosis with hypergamaglobulinemia had a normal proportion of B cells but that IgG 
and IgA hypergamaglobulinemia synthesis was markedly increased. The ESR is not raised by 
inflammation, infection or neoplasia to the extent that one would expect is largely due to lower 
fibrinogen level found in cirrhotics and to the lower kininogen level.
In our study all most all patients had hypergamaglobulinemia and all the 100 cases had 
albumin  globulin  ratio  reversal.  The  ratio  reversal  is  also  contributed  by  lower  albumin 
concentration due to decreased synthesis.
PLATELETS ABNORMALITIES
Defects of platelet number and function are well documented in patients with chronic 
liver  disease  contributing  significantly  to  their  hemostatic  abnormalities24.  Alcoholic  liver 
disease is associated with additional abnormalities which are probably a consequence of the 
toxic  effect  of  alcohol  on  platelet  production  and  function  is  evident  by  the  studies  by 
Mikhaitedes BMJ, 1986, Hillbom BMJ, 1987.
There  are  many  studies  that  demonstrate  diverse  mechanisms  of  thrombocytopenia. 
They are :
i. Shortened life span
ii. Platelet pooling in an enlarged spleen
iii. Inability of bone marrow to compensate
iv. Reduced thrombopoietin level
In our study the above findings are evident and out of  100 patients  13 patients  had 
thrombocytopenia < 1,00,000 / mm3 and 29 patients are i.e. the range of mild thrombocytopenia 
1 - 1.5 lakhs / mm3. All the  patients with count less than one lakh had history of bleeding 
tendencies and among then two patients had severe thrombocytopenia < 50,000 / mm3. Among 
the  patients,  four  patients  diagnosed to  have DIC,  which  also contributed  to  the  very  low 
platelet count in cirrhotics.
All  the  patients  with platelet  count  less  than one  lakh  had increased  bleeding time. 
Qualitative platelet abnormalities, assessed by template bleeding times and platelet aggregation 
studies may correlate with severity of chronic liver disease.31
ABNORMALITIES IN HEMOSTASIS
Liver  plays  a  major  role  in  regulating  hemostasis,  synthesizing  most  of  the  clotting 
factors  and  coagulation  inhibitors,  as  well  as  some  proteins  of  the  fibrinolytic  activated 
enzymes of the clotting and of the fibrinolytic systems.
As per the studies Manner EJ, 1992 and Colman RW and Rubier R.N. blood coagulation 
1988, clotting factors may be decreased even before any other evidence of liver damage. In 
hepato  cellular  failure  factor  VII  is  earlier  to  be  decreased  due  to  its  short  half  life  then 
followed by factors II and X. Factor IX is usually the last to be affected43,44.
These are vitamins K dependant proteins synthesized in Liver. If these deficiencies are 
unresponsive to parenteral  administration of vitamin K, it  can be assumed that  the hepatic 
synthesis of clotting factors is impaired46.
PROTHROMBIN TIME ABNORMALITIES
In our study 60 patients had elevated prothrombin value which is evident of clotting 
factor deficiency. They were also treated with vitamin K injection for a period of one week and 
the prothrombin time was repeated. Some show decrease in the prothrombin value50,51.
Factor V synthesized in liver independent of vitamin K and decreased level of factor V 
along with factors, II, VII, IX and X is an indicator of hepatocellular failure44.
APTT ABNORMALITY
APTT  is  prolonged  in  all  coagulation  defects  including  platelet  activity  and 
thromboplastin. Prolonged APTT is found in to :
1. Vitamin K deficiency
2. Liver disease
3. Presence of circulating anticoagulants
4. DIC disease
In our study four patients had found to have DIC and they have significant prolongation 
in APTT along with increased PT with severe thrombocytopenia. Other patients with history of 
bleeding tendencies had found to have moderately increased APTT.
According to oxford text book of hematology, APTT may be found to be moderately to 
highly prolonged according to the degree of liver failure. In case of moderate deficiencies of 
factor II, IX, X and V, associated with a high level of factor VIII the APTT will be normal.
DISSEMINATED INTRAVASCULAR COAGULATION
According  to  Sheila  Sherlock,  the  complex  changes  found  in  coagulation  proteins, 
inhibitors  and protein fragments usually associated with DIC could have been attributed to 
chronic liver diseases. According to studies by Bakkar CM, knot EAR Stibbe J. et al., thrombin 
-  antithrombin complexes,  soluble  fibrin  and fibrinogen degradation products  (D-dimer,  D-
monomer) suggest that low grade DIC is a component of coagulopathy in some patients with 
liver disease46,58.
The mechanism stimulating this are thought to include impaired clearance of activated 
clotting factors and endotoxemia.
In our study four patients were found to have DIC and it was confrmed with prologation 
of PT and APTT along with severe thrombocytopenia and was confirmed by estimation of D-
dimer. These patients were found to have septicemia, and they are culture positive showing 
gram negative organisms.
Thus with the above studies we inferred that many of the hematological abnormalities 
are  to  be  noticed  in  a  chronic  liver  disease  patient,  so  that  the  comorbidity  which  causes 
increased mortality can be decreased.
From the above study we noted that the severe anemia, present in increased proportion 
in women than men, and is not correlated with severity of disease as evident by serum bilirubin 
and hypoalbuminemia. Instead it is related with history of bleeding tendency.
The character of anemia defends upon the various factors such as bleeding tendencies, 
dietary deficiency, alcoholism, hemolytic syndromes. But normochromic normocytic anemia is 
most commonly found and mostly due to the primary pathology leads to hemodilution and 
chronic inflammation suppressing the bone marrow.
Macrocytosis is less common in females where the incidence of alcohol is less common.
Among the Leucocyte abnormalities, leucopenia which are found in cirrhosis as per the 
western literature is uncommon in our study. The leucocytosis is associated with infections 
mostly  of  secondary  peritonitis  due  to  repeated  paracentesis  and  spontaneous  bacterial 
peritonitis.
Platelet  abnormalities  as  assessed by Thrombocytopenia and increased bleeding time 
had no correlation with the severity of liver cell failure best associated in patients with large 
spleen and is more common in patients was bleeding tendencies,  a consequence of platelet 
defect.
Similarly prothrombin time and APTT are prolonged is more than 50% patients which 
can be correlated with the liver disease and there is significant rise in APTT along with severe 
thrombocytopenia is seen in patients with DIC.
CONCLUSION
1. According to  this  study conducted with a limited cases of 100 patients,  we inferred 
many conclusive results regarding the hematological and hemostatic abnormalities in a 
decompensated chronic liver disease patients.
2. In this study more than 80% of the patients had total protein less than normal and almost 
100% of patients had albumin - globulin ratio reversal.
3. Almost 80% of the patients had anemia in any one of the form.
4. Most  common anemia in cirrhosis  is  normo chromic normocytic  anemia as inferred 
from the study.
5. Microcytic anemia is most common among women and macrocytosis is rare.
6. Macrocytosis is almost common with alcoholics.
7. Abnormal red cells such as microcytes, macrocytes, target cells, anisocytosis are found 
to be common in cirrhosis.
8. Leucopenia is found to be rare as per the study and Leucocytosis are more common in 
patients with spontaneous bacterial periotonitis and secondary peritonitis.
9. Thrombocytopenia is present is more than 30% of patients and is commonly present in 
the patients with splenomegaly and with the history of bleeding tendencies.
10. Prothrombin time and activated partial thromboplastin time are prolonged is more than 
half of the patients. A significant rise in APTT with severe thrombocytopenia is found is 
DIC patients.
11. Hence with this study all the cirrhosis patients must be evaluated for hematological and 
hemostatic abnormalities and should be monitored for any complication. Early treatment 
to correct these comorbidities can decrease the mortality.
SUMMARY
In  our  prevalence study,  100 patients  admitted as inpatients  at  Government  General 
Hospital are taken for our study to assess the hematological profile and the hemostatic profile. 
All the patients were evaluated for the diagnosis of cirrhosis. Then patients were subjected to 
investigations for the hematological profile and hemostatic profile. Patients were done liver 
biopsy, upper GI endoscopy, USG abdomen and clinical signs for the diagnosis of cirrhosis. 
Blood investigations were done to assess the anaemia, nature of anemia, WBCs total count and 
differential count, platelet count, prothrombin time and APTT.
All the investigations were collected and tabulated. According to the study, the most 
common anemia in cirrhotics is normochromic normocytic  anaemia. Microcytosis occur in 
patients with bleeding tendencies and macrocytosis occur mostly in alcoholics.
Leucopenia occurs in a small fraction of patients and leucocytosis occurs in patients 
with history of repeated paracentesis and peritonitis. Eosinophilia is associated with parasitic 
infections.
Thrombocytopenia is present in most of the cirrhosis patients and are associated with 
increased bleeding tendencies. Most of the patients had increased prothrombin time and APTT 
due to decreased synthesis of clotting factors.
Thus in cirrhosis patients most of them had abnormalities in haematological parameters 
and hemostasis.
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ABBREVIATIONS AND ACRONYMS
CLD : Chronic liver disease
DCLD : Decompensated chronic liver disease
PT : Prothrombin time
APTT : Activated partial thromboplastin time
MCV : Mean corpuscular volume
MCH : Mean corpuscular hemoglobin
MCHC : Mean corpuscular hemoglobin concentration
PCV : Packed cell volume
TC : Total count
DC : Differential count
DIC : Disseminated intravascular coagulation
RBC : Red blood cells
WBCs : White blood cells
IL-1, IL-6 : Interleukin 1, 6
TNF - α : Tumor necrosis factor α
TIBC : Total iron binding capacity
HDL : High density lipoprotein
ie : That is
CT Scan : Computed Tomography Scan
HBV Ag : Hepatitis B virus antigen
HCV : Hepatitis C virus 
PROFORMA
Hematological profile in CLD
Name Age Sex IP No.
Occupation Address
Presenting complaints
History of present illness
Jaundice Pedal edema
Ascites Abdominal pain
Nausea vomiting Fever
Hemetemesis/Melena LOC/Fits/Confusion
Oliguria Chest pain
Constipation/diarrhoea
Other symptoms
Past H/o.
Diabetes Jaundice
Hypertension Trauma
Ischemic heart disease Blood transfusion
Tuberculosis Seizures/involuntary movements
Bronchial asthma Needle prick
Chronic kidney disease Surgery
Malignancy Drugs
Personal H/o.
Diet
Marriage status
Smoker
Alcohol
Iv drug abuse
Sexual history
Family H/o
CLD
Wilson's
Health of members of family
Clinical examination
General examination
Built Clubbing
Nourishment Cyanosis
Conscious Pedal edema
Oriented Lymphadenopathy
Febrile
Anaemia
Jaundice
Stigmata of CLD:
Face Hands
Telengectasia White nails
Xanthelasma Palmar erythema
KF ring Duputyren's contracture
Parotid enlargement
Paper money skin
Loss of eye brows
Jaundice
Endocrine Skin
Gynaecomastia Spider nevi
Testicular atrophy Scanty body hair
Slate gray pigmentation
                            Scratch marks
Vital signs
Pulse
Blood pressure
Temperature
Respiratory rate
Systemic examination
CVS
RS
CNS: Level of consciousness
Flapping tremors
Plantar reflex
Abdomen: Ascites Divarication of recti
Liver Umbilical hernia
Splenomegaly
Dilated veins over abdomen
Hernia and Hydrocele
Per rectal examination
Investigations
Blood TC Liver function test
DC S. Bilirubin
ESR SGOT
Hbgm% SGPT
RBC Count SAP
PCV γGT
MCV S.Albumin
MCH Total proteins
MCHC
Reticulocyte count Blood urea
Platelet count Sugar
BT Creatinine
CT Electrolytes
PT
APTT
Peripheral small for blood picture
Ascitic fluid:
Biochemical analysis
Cytology
Cell count
Fluid C/s
Chest X-ray
Abdomen erect x-ray
ECG in all leads
Ultrasound abdomen and pelvis
CT scan abdomen
Portal doppler
Upper GI endoscopy
Liver biopsy
Bone marrow studies
Viral markers
HBS Ag
Anti HCV antibody
